Vitamin D receptor expression as a predictive marker of biological behavior in human colorectal cancer

Clinical Cancer Research

Volumn 4, Issue 7, 1998, Pages 1591-1595

  Evans, Stephen R T ^a   Nolla, Jose ^b   Hanfelt, John ^b   Shabahang, Mohsen ^b   Nauta, Russell J ^b   Shchepotin, Igor B ^a  

^a GEORGE WASHINGTON UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; CANCER STAGING; COLORECTAL CANCER; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR BIOLOGY; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; TUMOR DIFFERENTIATION;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; COLORECTAL NEOPLASMS; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RECEPTORS, CALCITRIOL;

EID: 0031799004     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Parker, S. L., Tong, T., Bolden, S., and Wingo, P. A. Cancer statistics, 1996. CA Cancer J. Clin., 46: 5-27, 1996.
2. Takanishi, D. M., Hart, J., Covarelli, P., Chappell, R., and Michelassi, F. Ploidy as a prognostic feature in colonic adenocarcinoma. Arch. Surg., 131: 587-592, 1996.
3. Shibata, D., Reale, M. A., Lavin, P. H., Silverman, M., Fearon, E., Steele, G., Jessup, J. M., Loda, M., and Summerhayes, I. C. N. Engl. J. Med., 335: 1727-1732, 1996.
4. Iino, H., Fukayama, M., Maeda, Y., Koike, M., Mori, T., Takahashi, T., Kikuchi-yanoshita, R., Miyaki, M., Mizuno, S., and Watanabe, S. Cancer (Phila.), 73: 1324-1331, 1994.
5. Hamilton, S. R. Molecular genetic alterations as potential prognostic indicators in colon carcinoma. Cancer (Phila.), 69 (Suppl.): 1589-1591, 1992.
6. Potter, J. D. Reconciling the epidemiology, physiology, and molecular biology of colon cancer. J. Am. Med. Assoc., 268: 1573-1577, 1992.
7. Garland, C. F., Garland, F. C., Shaw, E. K., Comstock, G. W., Helsing, K. J., and Gorham, E. D. Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet, 2: 1176-1178, 1989.
8. Garland, D., Barrett-Connor, E., Rossof, A. H., Shekelle, R. B., Criqui, M. H., and Paul, O. Dietary vitamin D and calcium and risk of colorectal cancer: a 19-year prospective study in men. Lancet, 1: 307-309, 1985.
9. Haussler, M. R., and Norman, A. W. Chromosomal receptor for a vitamin D metabolite. Proc. Natl. Acad. Sci. USA, 62: 155-162, 1989.
10. Baker, A. R., McDonnnell, D. P., Hughes, M., Crisp, T. M., Mangelsdorf, D. S., Haussler, M. R., Pike, J. W., Shine, J., and O'Malley, B. W. Cloning and expression of full length cDNA encoding human vitamin D receptor. Proc. Natl. Acad. Sci. USA, 85: 3294-3298, 1988.
11. 3 receptors and human colon adenocarcinoma. Br. J. Surg., 78: 435-439, 1991.
12. Buras, R. R., Schumaker, L. M., Davoodi, F., Brenner, R. V., Shabahang, M., Nauta, R. J., and Evans, S. R. T. Vitamin D receptor in breast cancer cells. Breast Cancer Res. Treat., 31: 191-202, 1994.
13. 3 in gynecologic neoplasms. Gynecol. Oncol., 44: 131-136, 1992.
14. 3 in human malignant melanoma cell lines. J. Surg. Res., 61: 127-133, 1996.
15. 3 on the growth of soft-tissue sarcoma cells as mediated by the vitamin D receptor. Ann. Surg. Oncol., 3: 144-149, 1996.
16. 3 receptor as a marker of human colon carcinoma cell line differentiation and growth inhibition. Cancer Res., 53: 3712-3718, 1993.
17. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457-481, 1958.
18. Mantel, N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother. Rep., 50: 163-170, 1966.
19. Cox, D. R. Regression models and life tables. J. R. Stat. Soc. Ser. B, 34: 187-220, 1972.
20. Grambsch, P., and Therneau, T. M. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika, 81: 515-526, 1994.
21. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. J. Am. Med. Assoc., 264: 1444-1450, 1990.
22. 3 receptor in breast cancer and relationship to prognosis. Cancer Res., 51: 239-244, 1991.
23. 3 receptor in target cells. Endocrinology, 122: 1224-1230, 1988.
24. 3, inhibits azoxymethane-induced colonie turnorigenesis. Cancer Res., 55: 3050-3054, 1995.
25. Anzano, M. A., Smith, J. M., Uskokovic, M. R., Peer, C. W., Mullen, L. T., Letterio, J. J., Welsh, M. C., Shrader, M. W., Logsdon, D. L., Driver, C. L., Brown, C. C., Roberts, A. B., and Sporn, M. B. 1α,25-Dihydroxy-16-ene 23-yne-26,27-hexafluorocholecalciferol (Ro24-5531), a new deltanoid (vitamin D analogue) for prevention of breast cancer in the rat. Cancer Res., 54: 1653-1656, 1994.